1.97%| Prev Close: | 2.92 |
|---|---|
| Open: | 2.95 |
| Bid: | 2.81 |
| Ask: | 3.00 |
| 1y Target Est: | N/A |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 2.95 - 3.00 |
|---|---|
| 52wk Range: | 1.21 - 3.10 |
| Volume: | 12,450 |
| Avg Vol (3m): | 4,835 |
| Market Cap: | 69.89M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in AUD.
Headlines
- pSivida Corp. Reports Third Quarter Fiscal Year 2013 ResultsBusiness Wire(Tue 14 May)
- pSivida Corp. Reports Third Quarter Fiscal Year 2013 Resultsat Reuters(Tue 14 May)
- pSivida Corp. Announces Third Quarter 2013 Financial Results Release Date and Conference Call InformationBusiness Wire(Tue 7 May)
- pSivida Corp. Announces Third Quarter 2013 Financial Results Release Date and Conference Call Informationat Reuters(Tue 7 May)
- pSivida Corp. Announces New ILUVIEN® PDUFA Date of October 17, 2013Business Wire(Wed 1 May)
- pSivida Reports ILUVIEN® Available in UKBusiness Wire(Mon 29 Apr)
- pSivida Reports ILUVIEN® Available in UKat Reuters(Mon 29 Apr)
- pSivida Corp. President and CEO, Dr. Paul Ashton Publishes Blog Post Titled ''Transformational Change and Ophthalmology''Accesswire(Thu 18 Apr)
- pSivida Corp. President and CEO, Dr. Paul Ashton Publishes Blog Post Titled ''Transformational Change and Ophthalmology''Accesswire(Thu 18 Apr)
- pSivida Announces Launch of New Online Corporate Communication ChannelsBusiness Wire(Wed 10 Apr)
Press Releases
- pSivida Corp. Reports Third Quarter Fiscal Year 2013 Resultsat Reuters(Tue 14 May)
- pSivida Corp. Announces Third Quarter 2013 Financial Results Release Date and Conference Call Informationat Reuters(Tue 7 May)
- pSivida Reports ILUVIEN® Available in UKat Reuters(Mon 29 Apr)